Mainly driven by the high restructuring expenses in Q4 and the adjustments related to the impairment in Radiology Solutions, the Agfa-Gevaert Group posted a net loss of 92 million euro.
PM CET Regulated information Extraordinary General Meeting of Agfa-Gevaert NV Mortsel, Belgium – March 11, 2025 – 5.40 p.m. CET On Tuesday, March 11, Agfa held an Extraordinary General Meeting at its ...
Hello, and welcome to the Agfa Full Year 2024 Results Conference Call. Please note this call is being recorded. [Operator Instructions] I will now hand you over to your host, Mr. Pascal Juery, CEO ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
X-Ray Detectors Market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.2 billion ...
AGFA Gevaert NV reported strong financial performance for the fourth quarter of 2024, with significant contributions from its growth engines. The company’s stock surged 9.2% to close at €0.85 ...
(*) before adjustments and restructuring expenses (**) Adjusted EBIT/EBITDA with the deduction of adjustments and restructuring expenses reconciles to ‘Results ...
AGFA Gevaert NV reported strong financial performance for the fourth quarter of 2024, with significant contributions from its growth engines. The company’s stock surged 9.2% to close at €0.85, ...
CET The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets. The Agfa-G ...
The Agfa-Gevaert Group posted strong Q4 revenue growth, profitability and free cash flow, with record performances of its growth engines. The strong year-end resulted in significant full year revenue ...
The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets The Agfa-Gevaert Group posted strong Q4 revenue growth, profitability and free ...
Income tax expenses amounted to 15 million euro. Mainly driven by the high restructuring expenses in Q4 and the adjustments related to the impairment in Radiology Solutions, the Agfa-Gevaert Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results